Contribution of Data
The Global Burden of Disease study aims to provide estimates of prevalence, incidence, duration, mortality and disability for all diseases and injures. In addition risk factors will be assessed. Estimates will be made for age stratifications and sex groups.
NDARC and the University of Queensland are responsible for collecting data that will be used to makes estimates for mental disorders and illicit drug use. Systematic searches of peer reviewed literature and also grey literature are being conducted at present.
Contribution of primary research of high methodological standard is welcomed.
If you wish to contribute data to be used in the Global Burden of Disease study estimates please email your data and contact details to
Contributors
We appreciate the contributions of additional data and advice that have been provided by:
A - G
Dr Josep M. Haro Abad
Sant Joan de Deu – Serveis Salut Mental
Peter Allebeck
Department of Public Health Sciences, Section for Social Medicine
Dr Jordi Alonso
Principle Investigator WMHS, Spain
Dr Laura Andrade
Principle Investigator WMHS, Brazil
Dr Matthias Angermeyer
Principle Investigator WMHS, Germany
Dr Apinun Aramrattana
Northern Substance Abuse Centre, Chiang Mai University
Ruben Baler
National Institute on Drug Abuse, U.S.A.
Professor Anne Bartu
[4]
Curtin University of Technology, Perth
Francisco Inacio Bastos
Oswaldo Cruz Foundation, Brazil
Professor Paul Bebbington
University College London
Associate Professor James Bell
Langton Centre, Sydney
Jamie Bridge
International Harm Reduction Association
Dr Evelyn Bromet
Principle Investigator WMHS, Ukraine
Prof Mark Oakley Browne
Principle Investigator WMHS, New Zealand
Dr Ronny Bruffaerts
Principle Investigator WMHS, Belgium
Professor Terry Brugha
University of Leicester
Professor Andrew Cheng
Academia Sinica, Taipei
Nico Clark
World Health Organization
Carolyn Coffey
Centre for Adolescent Health, Melbourne
Dr Wilson Compton
National Institute on Drug Abuse, U.S.A.
Eva Congreve
National Drug and Alcohol Research Centre, Sydney
Professor Jan Copeland
National Drug and Alcohol Research Centre, Sydney
John Corkery
International Centre for Drug Policy
St George's University of London, London
Professor Shane Darke
National Drug and Alcohol Research Centre, Sydney
Dr Marina Davoli
Department of Epidemiology, Rome
Dr Koen Demyttenaere
Principle Investigator WMHS, Belgium
Jimmy Dorabjee
Centre for International Health
Burnet Institute, Melbourne
Jeremy Douglas
United Nations Office on Drugs and Crime, Vienna
Sarah Duffy
National Institute on Drug Abuse, U.S.A.
Prof William Eaton
Bloomberg School of Public Health
Dr Silvia Florescu
Principle Investigator WMHS, Romania
Dr Anna Fugelstad [2]
Karolinska Institutet, Stockholm
Associate Professor Sandro Galea
University of Michigan, Ann Arbor, MI
Dr Isabelle Gasquet
Principle Investigator WMHS, France
Isabelle Giraudon
EMCDDA, Lisbon
Dr Giovanni de Girolamo
Principle Investigator WMHS, Italy
Myer Glantz
NIDA
Professor Hamid Ghodse
University of London
Professor Gyles Glover
Durham University
Dr Ron de Graaf
Principle Investigator WMHS, Netherlands
Paul Griffiths
EMCDDA
Dr Oye Gureje
Principle Investigator WMHS, Nigeria
H - L
Professor Wayne Hall
University of Queensland, Brisbane
Dr Josep Maria Haro
Principle Investigator WMHS, Spain
Dr Morten Hesse
[1]
Aarhus Universitet , Aarhus, Denmark
Dr Matthew Hickman
Bristol University, Bristol
Dr Maureen Hillhouse
UCLA Integrated Substance Abuse Programs, USA
Dr Hristo Hinkov
Principle Investigator WMHS, Bulgaria
Alison Hoffnagle
Harvard Medical School, USA
Dr John Howard
National Drug and Alcohol Research Centre, Sydney
Yih-Ing Hser
[8]
Los Angeles Integrated Substance Abuse Programs, USA
Dr Chiyi Hu
Principle Investigator WMHS, Shenzhen
Dr Yueqin Huang
Principle Investigator WMHS, China
Marya Hynes
Inter-American Drug Abuse Control Commission (CICAD)
Eric Janssen
Emerging Trends Department, Observatiore Français des Drogues et des toxicomanies
French Monitoring Centre for Drug and Drug Addiction, France
Professor Rachel Jenkins
Institute of Psychiatry Kings College , London
Professor Li Jianhua
Yunnan Institute for Drug Abuse, China
Robert Jin
Harvard School of Medicine, USA
Dr Elie Karam
Principle Investigator WMHS, Lebanon
Dr Norito Kawakami
Principle Investigator WMHS, Japan
Dr Sharlene Kaye
National Drug and Alcohol Research Centre, Sydney
Dr Cille Kennedy
DHHS/ASPE, Washington DC
Professor Thomas Kerr
[5]
British Columbia Centre for Excellence in HIV/AIDS
University of British Columbia, Vancouver
Prof Ronald c Kessler
Harvard School of Medicine, USA
Assistant Professor Gregory Kirk
Johns Hopkins University, USA
Danica Klempova
EMCDDA, Lisbon
Dr Viviane Kovess
Principle Investigator WMHS, France
Dr Ludwig Kraus
Institut für Therapieforschung, Germany
Kevin Kramer
University of Pittsburgh School of Medicine, Pittsburgh
Aneke Krol [10]
GGD Amsterdam, Netherlands
Prof Ronaldo Laranjeira
Federal University of São Paulo
Dr Sing Lee
Principle Investigator WMHS, China
Dr Jean-Pierre Lepine
Principle Investigator WMHS, France
Dr Daphna Levinson
Principle Investigator WMHS, Israel
Kathy Li
British Columbia Centre for Excellence in HIV/AIDS
University of British Columbia, Vancouver
Dominique Lopez
EMCDDA, Lisbon
Marsha Lopez
National Institute on Drug Abuse, U.S.A.
Michael Lynskey, PhD
Department of Psychiatry, Washington University School of Medicine
M - Q
David Macdonald
International Drugs and Development Advisor
Dr John Macleod
University of Bristol
Dr. Greg Martin
Nationa Drug and Alcohol Research Centre, Sydney
Hélène Martineau
Emerging Trends Department, Observatiore Français des Drogues et des toxicomanies
French Monitoring Centre for Drug and Drug Addiction, France
Dr Bradley Mathers
National Drug and Alcohol Research Centre, Sydney
Professor Jane Maxwell
University of Texas, Austin
Professor John McGrath
Queensland Centre for Mental Health Research, Brisbane
Dr Rebecca McKetin
National Drug and Alcohol Research Centre , Sydney
Dr Maria Elena Medina-Mora
National Institute of Psychiatry, Mexico City
Associate Professor Shruti Mehta
Johns Hopkins University, USA
Professor Terrie Moffitt
Duke University, Durham, NC
Matthew Nice
United Nations Office on Drugs and Crime, Vienna
Carlos Nordt, PhD
[6]
Psychiatric University Hospital, Zurich
Dr J. Hans Ormel
Principle Investigator WMHS, Netherlands
Michael Otim
National Drug and Alcohol Research Centre, Sydney
Alexander Pabst
IFT Institut für Therapieforschung, Munich
Dr Samiran Panda
Society for positive atmosphere and related support to HIV/AIDS, West Bengal, India
Andreas Plüddemann
Alcohol & Drug Abuse Research Unit
Medical Research Council, Cape Town
Dr Guilherme Polanczyk
Federal University of Rio Grande do Sul, Porto Alegre, Brazil
Dr Jose Posada-Villa
Principle Investigator WMHS, Colombia
Dr Rumi Kato Price
[9]
Washington University, USA
Dr Toma Tomov Principle
Principle Investigator WMHS, Bulgaria
Vu Minh Quan, M.D, Assistant Professor
[3]
John Hopkins University Bloomberg School of Public Health, Baltimore
R - Z
Professor Richard Rawson
Department of Psychiatry, UCLA, Los Angeles
Erin P. Ricketts
[7]
Johns Hopkins Bloomberg School of Public Health, ALIVE study, Baltimore, MD
Professor Alison Ritter
National Drug and Alcohol Research Centre, Sydney
Amanda Roxburgh
National Drug and Alcohol Research Centre, Sydney
Dr Rajesh Sagar
Principle Investigator WMHS, India
Nancy Sampson
Harvard School of Medicine, USA
Dr Shekhar Saxena
WHO, Geneva
Jane Shelling
Alcohol and other Drugs Council of Australia
Dr Tim Slade
National Drug and Alcohol Research Centre, Sydney
James Shearer
The Langton Centre, Sydney
National Drug and Alcohol Research Centre, Sydney
Professor Eliot Sorel
George Washington University
Dr Wendy Swift
National Drug and Alcohol Research Centre, Sydney
Pascal Tanguay
Asian Harm Reduction Network
Kiusiang Tay
University of Melbourne, Melbourne
Abdalla Toufik
Emerging Trends Department, Observatiore Français des Drogues et des toxicomanies
French Monitoring Centre for Drug and Drug Addiction, France
Alex Tsai
Yaffa Tzubery
The Israel Anti Drug Authorit, Israel
Dr Maria Carmen Viana
Principle Investigator WMHS, Brazil
Julian Vicente
EMCDDA, Lisbon
Konstantin Vyshinsky
United Nations Office on Drugs and Crime, Moscow
Susan Weiss
National Institute on Drug Abuse, U.S.A.
Prof J. Elisabeth Wells
Principle Investigator WMHS, New Zealand
Dr David Williams
Principle Investigator WMHS, South Africa
Associate Professor Katrina Williams
Sydney Childrens Hospital, University of New South Wales, Sydney
Dr Evan Wood
Urban Health Research Initiative, Vancouver
Dr Tomas Zabransky
Institute of Preventive Medicine, Olomouc, Czech Republic
Dr Mingyuan Zhang
Principle Investigator WMHS, China
[1] Fridell, M. and M. Hesse (2006). "Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users." Addictive Behaviors 31(4): 559-65.
[2] Fugelstad, A., A. Annell, J. Rajs and G. Agren (1997). "Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992."
Acta Psychiatrica Scandinavica 96(3): 169-175.
[3] Quan, V. M., T. Vongchak, J. Jittiwutikarn, S. Kawichai, N. Srirak, K. Wiboonnatakul, M. H. Razak, V. Suriyanon and D. D. Celentano (2007). "Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand." Addiction 102(3): 441-446.
[4] Bartu, A., N. C. Freeman, G. S. Gawthorne, J. P. Codde and C. D. A. J. Holman (2004). "Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia.
[see comment]." Addiction 99(1): 53-60.
[5] Miller, C.L., T. Kerr, S.A. Strathdee, K. Li, and E. Wood (2007). "Factors associated with premature mortality among young injection drug users in Vancouver." Harm Reduction Journal 4(1)
[6] Nordt, C. and R. Stohler (2006). "Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis." Lancet 367: 1830-1834.
[7] Wang, C., D. Vlahov, N. Galai, S.R. Cole, J. Bareta, R. Pollini, S.H. Mehta, K.E. Nelson and S. Galea (2005). "The effect of HIV infection on overdose mortality." AIDS 19: 935-942.
[8] Hser, Y., Evans, E., Huang, D., Brecht, M. L., & Li, L. (2008). Comparing the dynamic course of heroin, cocaine and metampehtamine use over 10 years. Addictive Behaviours, 33, 1581-1589.
[9] Price, R. K., Risk, N. K., & Spitznagel, E. L. (2001). Remission from drug abuse over a 25 year period: patterns of remission and treatment use. American Journal of Public Health, 91 (7), 1107 - 1113.
[10] Van Haastrecht, H. J. A., E. J. C. Van Ameijden, et al. (1996). "Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users." American Journal of Epidemiology 143 (4): 380-391.